France· FR:68323818
RESPREEZA 1000 mg, poudre et solvant pour solution injectable/ perfusion
A medicinal product containing alpha-1 antitrypsine humaine, registered in France by CSL BEHRING (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ALPHA-1 ANTITRYPSINE HUMAINE
- Manufacturer
- CSL BEHRING (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009550124361 flacon(s) en verre de 1000 mg - 1 flacon(s) en verre de 20 ml avec dispositif(s) de transfert 20/20 (dispositif Mix2Vial)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Alpha-1 antitrypsine humaine in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandProlastinaGrifols Deutschland GmbH
- CzechiaPROLASTINAGrifols Deutschland GmbH, Frankfurt
- SwedenProlastina 1000 mg Pulver och vätska till infusionsvätska, lösningGrifols Deutschland GmbH
- NorwayProlastinaGrifols Deutschland GmbH
- PolandRespreezaCSL Behring GmbH
- IrelandProlastin 4000 mg, powder and solvent for solution for infusionGrifols Deutschland GmbH
- IcelandRespreezaCSL Behring GmbH*
- United StatesGLASSIATakeda Pharmaceuticals America, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Prolastin
- Belgium · Pulmolast
- Cyprus · Prolastina
- Czechia · Prolastina
- Germany · Prolastin
- Denmark · Prolastina
- Spain · Prolasplan, Prolastina
- Finland · Prolastina
- Greece · Prolastin
- Croatia · Prolastina
- Ireland · Prolastin
- Iceland · Respreeza
- Italy · Plitalfa, Prolastin
- Liechtenstein · Respreeza
- Netherlands · Prolastin
- Norway · Prolastina, Respreeza
- Poland · Prolastin, Prolastin, 4000 Mg
- Portugal · Prolastin
- Sweden · Prolastina
- Slovakia · Prolastina
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ba2baaff-d377-4d80-a2b7-edb33051f403 GET /v1/drugs/ba2baaff-d377-4d80-a2b7-edb33051f403?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "68323818",
"date_amm": "2015-08-20",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/15/1006",
"substance": "ALPHA-1 ANTITRYPSINE HUMAINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour solution injectable et pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about alpha-1 antitrypsine humaine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.